The effects of menthol on the pharmacokinetics of nicotine and tobacco-specific nitrosamines
Ended Awarded Last action
- Contract number
- HHSF22301001T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,640,749
Award facts
- Opportunity
-
- 14223SOL00077 Solicitation number
- In Vivo Toxicology of Tobacco and Related Products Award Notice · Posted Aug 5, 2014
- Contract value 100% obligated
- $1,640,749.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,640,749 |
About this award
This is a firm-fixed-price delivery order under the "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract, awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The contract is for studying the effects of menthol on the pharmacokinetics of nicotine and tobacco-specific nitrosamines, with a ceiling value of $1,640,749.00 and a period of performance ending on July 31, 2019. The contract has no set-aside designation.
Quick answers
Who was awarded contract HHSF22301001T?
HHSF22301001T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Food and Drug Administration (Department of Health and Human Services) on July 28, 2016.
How much is contract HHSF22301001T worth?
The government has obligated $1,640,749 on HHSF22301001T.
Is contract HHSF22301001T an order under another contract?
Yes. HHSF22301001T is a delivery order under HHSF223201510032I, an indefinite delivery contract, on In Vivo Toxicology of Tobacco 2015-2020.
Was contract HHSF22301001T competed?
The extent of competition for HHSF22301001T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award